542918 Stock Overview
Gian Life Care Limited provides diagnostic and related healthcare tests and services in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Gian Life Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹20.40 |
| 52 Week High | ₹29.00 |
| 52 Week Low | ₹18.16 |
| Beta | 0.41 |
| 1 Month Change | -8.40% |
| 3 Month Change | -10.88% |
| 1 Year Change | -10.88% |
| 3 Year Change | 220.57% |
| 5 Year Change | n/a |
| Change since IPO | 104.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542918 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -1.2% | -4.1% | -2.5% |
| 1Y | -10.9% | 61.1% | 44.5% |
Return vs Industry: 542918 underperformed the Indian Healthcare industry which returned 65% over the past year.
Return vs Market: 542918 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 542918 volatility | |
|---|---|
| 542918 Average Weekly Movement | 7.4% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 542918's share price has been volatile over the past 3 months.
Volatility Over Time: 542918's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Arun Gupta | gianlifecare.org |
Gian Life Care Limited provides diagnostic and related healthcare tests and services in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services to its patients and healthcare providers. The company was incorporated in 2018 and is based in Kanpur, India.
Gian Life Care Limited Fundamentals Summary
| 542918 fundamental statistics | |
|---|---|
| Market cap | ₹210.97m |
| Earnings (TTM) | ₹10.69m |
| Revenue (TTM) | ₹100.64m |
19.7x
P/E Ratio2.1x
P/S RatioIs 542918 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542918 income statement (TTM) | |
|---|---|
| Revenue | ₹100.64m |
| Cost of Revenue | ₹22.45m |
| Gross Profit | ₹78.18m |
| Other Expenses | ₹67.49m |
| Earnings | ₹10.69m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.03 |
| Gross Margin | 77.69% |
| Net Profit Margin | 10.62% |
| Debt/Equity Ratio | 8.9% |
How did 542918 perform over the long term?
See historical performance and comparison